Skip to main content
Equibles

Alexandria Hammond

Analyst

Wolfe Research

Equibles does not estimate personal net worth.

About Alexandria Hammond

Alexandria Hammond is recorded as Analyst at Wolfe Research. Alexandria Hammond has spoken on 6 earnings calls and 1 other investor event across 5 companies, most recently for Regeneron Pharmaceuticals, Inc. on October 1, 2026. Those appearances were for Regeneron Pharmaceuticals, Inc. (REGN), Johnson & Johnson (JNJ), Zealand Pharma A/S (ZLDPF), Moderna, Inc. (MRNA) and Bristol Myers Squibb Co (BMY). The companies whose calls Alexandria Hammond spoke on are classified in the Healthcare sector.

Alexandria Hammond on recent calls

“So you and a competitor show some data this morning at EADV and that drug is now moving into phase three trials to demonstrate superiority over depictant.”
Analyst — Wolfe Research, Regeneron & Sanofi Investor Event ·
“I guess as you think about the Phase II readout for petrolintide and CT38 combo, is there a specific efficacy threshold that that combo needs to clear to justify moving into the Phase III?”
Analyst — Wolfe Research, Q1 Financial Results / Interim Report First Quarter 2026 ·
“So with the recent approval of the COVID flu vaccine in the EU, can you just walk us through your commercialization strategy, and I guess, what does a successful launch look like a year from now and five years from now?”
Analyst — Wolfe Research, Moderna, Inc. Q1 FY2026 Earnings Call ·
“On Novexian, given the size and breadth of the Labrexia program, it seems like there's probably a rich set of outcomes between a clean win and miss.”
Analyst — Wolfe Research, Bristol Myers Squibb Co Q1 FY2026 Earnings Call ·
“Can you walk us through the investments you guys are making on prescriber and patient education and how important do you think advertising will be to kind of engage those new patients who might be nervous to start on a systemic therapy?”
Analyst — Wolfe Research, Johnson & Johnson First Quarter 2026 Earnings Call ·

Affiliation history

  • Wolfe Research

    Analyst

    Source not stated

    Current

Company network

Recent activity